1. Home
  2. AMN vs KROS Comparison

AMN vs KROS Comparison

Compare AMN & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMN Healthcare Services Inc

AMN

AMN Healthcare Services Inc

HOLD

Current Price

$20.49

Market Cap

656.1M

Sector

Health Care

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$15.53

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMN
KROS
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Assisted Living Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
656.1M
584.9M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
AMN
KROS
Price
$20.49
$15.53
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$22.25
$23.00
AVG Volume (30 Days)
1.5M
252.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.58
3.85
EPS
N/A
2.68
Revenue
$1,988,454,000.00
N/A
Revenue This Year
N/A
$6,898.87
Revenue Next Year
$4.07
N/A
P/E Ratio
N/A
$5.83
Revenue Growth
4.53
N/A
52 Week Low
$14.97
$9.12
52 Week High
$27.17
$22.55

Technical Indicators

Market Signals
Indicator
AMN
KROS
Relative Strength Index (RSI) 62.35 27.95
Support Level $20.12 $15.12
Resistance Level $22.01 $16.12
Average True Range (ATR) 1.38 0.59
MACD 0.07 -0.13
Stochastic Oscillator 89.76 3.02

Price Performance

Historical Comparison
AMN
KROS

About AMN AMN Healthcare Services Inc

AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are; nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. A majority of its revenue is generated from the nurse and allied solutions segment which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: